The Food and Drug Administration is still in turmoil, but Wall Street no longer cares.

The nonprofit is aiming to inspire a new moonshot effort that helps the U.S. maintain its position as a drug innovation ...

Biotech is increasingly financed, governed and regulated as though it were a mature pharmaceutical industry rather than a ...

China's ascent is forcing U.S. biotech companies and investors to pick a side: Is it an ally or an existential threat?

Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...

China’s rise is happening with the blessing of U.S. pharmaceutical executives, who are allowing their own industry to be ...

The Nasdaq Biotechnology™ Index (NBI®) has been the leading benchmark for the biotech industry since its launch in 1993, reflecting Nasdaq’s historical dominance in attracting biotech IPOs with an ...

Drug companies have cut nearly 69,000 pharmaceutical jobs since the start of 2021. A single biotech job posting now attracts ...

Biotech ETFs can help investors capitalize on health care innovation while avoiding the boom-or-bust nature of individual ...

The biotechnology industry is nearly as old as the personal computer, but it lacks a Steve Jobs-like figure that the broader ...

table { width: 100%; border-collapse: collapse; font-family: Arial, sans-serif; font-size: 14px; } th, td { padding: 8px; text-align: left; } th { background-color ...